The approval follows the European Commission authorization and the first launch in Germany earlier this year, with additional launches in Europe to follow.
Short-sightedness is rising fast among children in the UK, where many children now live with myopia, more than double the number from 50 years ago. Increased screen time, less outdoor activity, and intensive near work are putting a growing strain on young eyes. Globally, approximately one in three children and adolescents are expected to be affected by 2050.
“We have a critical window in childhood to recognize myopia and act early,” said Professor Annegret Dahlmann-Noor, expert in myopia management in London. Childhood myopia increases the risk of severe eye disease later in life. “A comprehensive approach, combining lifestyle habits, optical correction, and approved medical options, gives children the best chance to support healthy vision into adulthood.”
“The UK approval is an important milestone in improving awareness and access to care for children with short-sightedness,” said Neil Parkin, General Manager UK & Ireland, Santen. “We want to help shift the conversation from correction to control, supporting clinicians, schools, and parents to take early action.”
